Reducing headcount by 50% to further extend capital resources Cash runway extended to at least mid-2024 Cystic Fibrosis Program remains on track with initial readout from Phase 1b/2a study of BX004 expected in the third quarter of 2022 and readout from part 2 of the study expected in the first quarter of 2023 Atopic Dermatitis … [Read more…]
– Pivotal data on glofitamab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody in heavily pre-treated patients with aggressive lymphoma, will be presented as part of our industry-leading hematology portfolio – – Further studies exploring broad genomic testing to support informed treatment decisions for patients and advance cancer care approaches will be presented – SOUTH … [Read more…]
NEW YORK–(BUSINESS WIRE)–DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services and integrated medical transportation solutions, announced today that its Board of Directors has authorized a share repurchase program pursuant to which the Company may purchase up to $40 million of its Common Stock. “DocGo continues to revolutionize the delivery of healthcare, and … [Read more…]
Poster presentations on SNR1611, an experimental small molecule treatment for Alzheimer’s Disease, to be presented at Keystone Symposium on Neurodegeneration, June 5-9 Online abstract publication on GNUV201, a novel monoclonal antibody for cancer immunotherapy, at the American Society of Clinical Oncology Meeting, June 3-7 SEOUL, South Korea–(BUSINESS WIRE)–Genuv Inc., a clinical-stage biotechnology company focused on … [Read more…]
IntelliCentrics tech platform is uniquely positioned to transform how care is delivered, received and paid for through the company’s network of stakeholders across 10,000 locations of care including North America, Taiwan and the United Kingdom on a single technology platform. DALLAS–(BUSINESS WIRE)–IntelliCentrics (6819.HK) connects trusted stakeholders across the continuum of care by delivering valuable, technology-enabled … [Read more…]
Improving Air Purification Market Trends MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced its financial results for the … [Read more…]
Donation drive draws awareness of how Give an Hour provides no-cost mental health care PHOENIX–(BUSINESS WIRE)–University of Phoenix is holding a monthlong employee donation drive in support of Give an Hour®, a non-profit organization that connects veterans and military community members to free mental health resources through a network of mental health providers who donate … [Read more…]
NOVA LIMA, Brazil–(BUSINESS WIRE)–Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition, through its wholly-owned subsidiary Afya Participações S.A, of 100% of Glic. Glic is a free diabetes care and management app solution for physicians and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and health providers. … [Read more…]
High and Predictable Growth Full Year 2022 Guidance Reaffirmed Robust EPS Expansion NOVA LIMA, Brazil–(BUSINESS WIRE)–Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2022 (first quarter 2022). Financial results are … [Read more…]
Recent Filing Only Intended as a Distraction to Shareholders and has No Impact on Blue Ocean Campaign to STOP the Cellenkos Transaction NEW YORK–(BUSINESS WIRE)–Blue Ocean Structure Investment Company Ltd. (“Blue Ocean”), a significant shareholder of Global Cord Blood Corporation (the “Company” or “Global Cord”) (NYSE: CO), today commented on what Blue Ocean believes to … [Read more…]
